Cardiol Therapeutics Inc.

NasdaqCM:CRDL Stock Report

Market Cap: US$95.6m

Cardiol Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:CRDL Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
26 Dec 24BuyUS$21,721Guillermo Torre-AmioneIndividual17,240US$1.26
19 Dec 24BuyUS$24,727Andrew HamerIndividual18,900US$1.31
18 Dec 24BuyUS$28,333Guillermo Torre-AmioneIndividual21,548US$1.45
17 Dec 24BuyUS$13,617Bernard LimIndividual10,000US$1.36
17 Dec 24BuyUS$49,968Peter PekosIndividual38,750US$1.29
16 Dec 24BuyUS$52,741David ElsleyIndividual40,000US$1.32
16 Dec 24BuyUS$34,918Christopher WaddickIndividual25,900US$1.35
24 Jun 24BuyUS$101,439David ElsleyIndividual50,000US$2.03

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CRDL?
Owner TypeNumber of SharesOwnership Percentage
Private Companies15,0050.0182%
Individual Insiders3,886,4424.7%
Institutions7,847,2849.5%
General Public70,880,26185.8%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 19.8%.

Top Shareholders

Top 25 shareholders own 13.86% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
3.87%
Tejara Capital Limited., Asset Management Arm
3,194,990US$3.7m2.55%1.83%
1.51%
David Elsley
1,244,500US$1.4m0%no data
1.19%
AdvisorShares Investments, LLC
982,488US$1.1m11.3%0.15%
1.03%
Michael Willner
851,580US$984.9k0%no data
0.95%
MM Asset Management Inc
782,625US$905.2k-1.63%0.09%
0.67%
UBS Asset Management AG
552,857US$639.4k135%no data
0.61%
Peter Pekos
506,040US$585.3k0%no data
0.59%
PVG Asset Management Corp
487,295US$563.6k0%2.5%
0.56%
Andrew Hamer
466,613US$539.7k0%no data
0.4%
Lion Street Advisors, LLC
333,725US$386.0k8.47%0.12%
0.4%
Envestnet Asset Management, Inc.
329,149US$380.7k6.29%no data
0.39%
Cambridge Investment Research Advisors, Inc.
321,285US$371.6k-2.79%no data
0.31%
Guillermo Torre-Amione
259,309US$299.9k0%no data
0.17%
Colin Stott
142,500US$164.8k0%no data
0.17%
Atria Investments, Inc.
139,053US$160.8k2.33%no data
0.16%
Christopher Waddick
135,900US$157.2k0%no data
0.15%
Jennifer Chao
120,000US$138.8k20%no data
0.15%
Teri Loxam
120,000US$138.8k0%no data
0.12%
Knoll Capital Management
100,000US$115.7k0%0.09%
0.12%
MGO One Seven LLC
100,000US$115.7k0%no data
0.082%
Cetera Investment Advisers LLC
67,564US$78.1k55.2%no data
0.072%
Morgan Stanley, Investment Banking and Brokerage Investments
59,613US$69.0k-70.9%no data
0.067%
PMG Investment Solutions AG
55,000US$63.6k0%0.02%
0.063%
Geode Capital Management, LLC
52,435US$60.6k0%no data
0.061%
BMO Asset Management Corp.
50,079US$57.9k0.16%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/28 05:07
End of Day Share Price 2025/05/28 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cardiol Therapeutics Inc. is covered by 6 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Edward NashCanaccord Genuity
Christian OrqueraFirst Berlin Equity Research GmbH
Vernon BernardinoH.C. Wainwright & Co.